BRIEF-Opexa Therapeutics qtrly loss per share $0.28
November 14, 2016 at 07:52 AM EST
* Opexa -believes has sufficient liquidity to support current activities in winding down abili-t trial and for general operations
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.